Research Opportunities
Opportunity to co-develop a cannabinoid-related adverse events tool
The safety profile of therapeutic interventions is determined using data from clinical trials and real-world studies. As the use of medical cannabis continues to grow globally, it is imperative to establish a unified system so we can determine the safety and tolerability of cannabinoids. Developing a standardized approach would allow researchers to combine and compare data across studies, strengthening our ability to synthesize evidence on medical cannabis.
C4T is developing a cannabinoid-related adverse events tool for use in children and adults. They would like to invite you to participate in this process. Eligible participants include people with lived experience administering, authorizing, advising, or caring for people using cannabis for medical purposes.
Survey 1 will launch in fall 2024, focused on determining which adverse effects should be included in the tool. Survey 2, expected to launch in winter 2024, will focus on grading criteria. Your participation in the project will be acknowledged on the resulting publication which will describe the tool’s developmental process and findings. Your responsibility will be to participate in a Delphi by completing a minimum of two electronic surveys
- To participate on the cannabinoid-related adverse events tool please click here. https://redcap.link/74awzsm9.
If you have questions regarding the initiative, please contact Jessica Steer at jessica.steer@umanitoba.ca. Your knowledge, insights, and dedication will be invaluable to the success of this initiative. C4T (medcannkids.ca) is a group of researchers, regulators and health care providers who believe there is an urgent need to improve the quality of information gathered on cannabinoid-related adverse events, and we are hoping that you might be willing to help.
Thank-you for considering this invitation. Please share this invitation with others from your network!
Launching MC-RWE
The Medical Cannabis Real-World Evidence study
MC-RWE Study under Dr. Hance Clarke is recruiting patients and prescribers evaluating genetically verified medical cannabis products and validated patient-reported outcomes.
Get involved in research!
For more information, go to our website
From here, you can learn more about e-portal access, or download a copy of the medical document to be faxed
To contact the study coordinator, reach out to the study coordinator at 416-340-4800 x 4251 or Email at mcrwe@uhn.ca
If you’re ready to sign on to the e-portal as a recruiting prescriber, click here
Cannabis in the treatment of anxiety disorders
The MacAnxiety Research Centre at McMaster University (http://www.macanxiety.com/) is currently recruiting patients for an 8-week research study using cannabis oil capsules, where we hope to evaluate how CBD or a combination of CBD and THC may be used to improve the symptoms of anxiety disorders.
The principal investigator is Dr. Michael Van Ameringen
The study is being conducted at MacAnxiety Research Centre in Hamilton, Ontario
For additional information, please call (905)921-7644, or
Email: macanxietyresearch@gmail.com
This study has been reviewed and approved by the Hamilton Integrated Research Ethics Board under REB# 5748
